-
Recent news
- Neurim Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of Piromelatine for the Treatment of Insomnia
- Neurim Pharmaceuticals reports the results of stabilometric study of Circadin® demonstrating maintenance of postural stability
- Neurim Pharmaceuticals announces positive results from phase I and Ib clinical trials with Neu-P11, a sleep maintenance drug
